MMG
REGN icon

Monetary Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Monetary Management Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-712
Closed -$550K – 340
2026
Q1 		$550K Hold
712
– – 0.13% 137
2025
Q4 		$550K Sell
712
-135
-16% -$91.7K 0.13% 135
2025
Q3 		$476K Sell
847
-200
-19% -$113K 0.11% 148
2025
Q2 		$550K Sell
1,047
-60
-5% -$33.5K 0.14% 136
2025
Q1 		$702K Sell
1,107
-680
-38% -$468K 0.19% 112
2024
Q4 		$1.27M Buy
1,787
+210
+13% +$176K 0.33% 68
2024
Q3 		$1.66M Buy
1,577
+100
+7% +$111K 0.43% 50
2024
Q2 		$1.55M Buy
1,477
+80
+6% +$77.6K 0.41% 50
2024
Q1 		$1.34M Buy
1,397
+210
+18% +$200K 0.37% 62
2023
Q4 		$1.04M Buy
1,187
+92
+8% +$75.8K 0.33% 78
2023
Q3 		$901K Buy
1,095
+50
+5% +$39.3K 0.3% 84
2023
Q2 		$751K Sell
1,045
-200
-16% -$154K 0.23% 100
2023
Q1 		$1.02M Hold
1,245
– – 0.3% 85
2022
Q4 		$898K Hold
1,245
– – 0.28% 91
2022
Q3 		$858K Hold
1,245
– – 0.28% 89
2022
Q2 		$736K Hold
1,245
– – 0.23% 91
2022
Q1 		$870K Sell
1,245
-50
-4% -$31.6K 0.23% 90
2021
Q4 		$818K Sell
1,295
-1,545
-54% -$950K 0.2% 95
2021
Q3 		$1.72M Buy
2,840
+1,520
+115% +$944K 0.47% 52
2021
Q2 		$737K Buy
+1,320
New +$669K 0.22% 95
2017
Q1 		– Sell
-50
Closed -$18K – 310
2016
Q4 		$18K Hold
50
– – 0.01% 275
2016
Q3 		$20K Hold
50
– – 0.01% 275
2016
Q2 		$17K Hold
50
– – 0.01% 283
2016
Q1 		$18K Sell
50
-220
-81% -$90.7K 0.01% 275
2015
Q4 		$147K Buy
270
+20
+8% +$10.8K 0.07% 163
2015
Q3 		$116K Buy
+250
New +$134K 0.06% 172
2015
Q2 		– Sell
-50
Closed -$23K – 357
2015
Q1 		$23K Buy
+50
New +$21.2K 0.01% 309

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Monetary Management Group's REGN Position: Q2 2026 in Review

Monetary Management Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 712 shares — an estimated $550K sold.

Monetary Management Group first reported a position in REGN in Q1 2015 and held it in 27 quarters. The position peaked at $1.72M in Q3 2021. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Monetary Management Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Monetary Management Group sold 712 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $550K.
  • Monetary Management Group first reported a position in Regeneron Pharmaceuticals in Q1 2015 and held it in 27 quarters.
  • Monetary Management Group's Regeneron Pharmaceuticals position peaked at $1.72M in Q3 2021.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.